Immunotherapy uptake, biomarker-led precision care and next-generation targeted agents are reshaping treatment, while late diagnosis and drug resistance sustain unmet need.Dublin, Sept. 30, 2026 ...

Cancer epidemiology is not merely about counting cases; it is a dynamic field that informs screening policies, resource allocation, and clinical trial design. With rapid changes in risk factor ...

Overall cancer deaths in the United States continue to decline, but trends are mixed when it comes to deaths associated with specific cancer types and overall cancer incidence, according to the 2025 ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine cancer increased an average of 0.7% each year between 2013 and 2022 and ...

Over the past two decades, there has been a significant increase in the incidence of primary liver cancer in the USA, with higher rates observed in men. Its burden increases with age and ...